Daily FNArena News

Optiscan continues to generate sales of its flexible endo-microscope, while clinical trial success of its rigid version potentially opens up new opportunities.

Rio Tinto’s Chief Executive Iron Ore left analysts at JP Morgan with the impression that iron ore prices will go up further as the market has commenced to pencil in.

ABN Amro Morgans rates both Peplin and Ventracor as Buys, expecting both stocks to enjoy positive news flow in coming months thanks to successful trial results and growing product awareness.

Citigroup analysts are bullish on the prospects for the gold price, and note significant opportunities in gold miners if you stick to the majors.

Bank of Queensland’s profit result was better than the market has expected, but brokers continue to view the stock as overpriced.

Shaking off yesterday’s blues, Wall Street powered ahead on favourable reporting featuring retailers and tech stocks.

Weekly musings from your editor (with apologies for the delay).

Employment grew again last month, lending weight to RBA governor Glenn Stevens’ arguments yesterday regarding the economy, and to chances of a November hike.

Forecasts for the yen against the US dollar are being revised lower, but conditions are in place for the Asian currency to rally against the greenback into next year.

Port Of Tauranga shares rose strongly yesterday after the company revealed merger discussions with Port of Auckland, though regulatory issues pose a threat to any deal being approved.